Testing a blood test to tell endometriosis from ovarian cancer
Part of Women’s health & pregnancy clinical trials.
This study is testing a new blood test (called OCS) to see if it can help tell the difference between endometriosis and a type of ovarian cancer that can look like endometriosis. If you are about to have surgery for endometriosis or a possible ovarian tumor, joining this study could help doctors learn if the OCS test is accurate for people like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older with a new diagnosis of endometriosis or a suspicion of endometriosis-related ovarian cancer, based on ultrasound or MRI.
- You are planning to have surgery to treat your condition, and your ovary will be tested after surgery.
- You must not be pregnant or breastfeeding.
- You have not had previous surgery that gave a definite diagnosis of your ovarian condition.
- You have not had chemotherapy or radiation to your pelvis in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood and small tissue samples during planned gynecological surgery to better diagnose endometriosis and predict its course. It may help future patients by making diagnoses and outlook more accurate.
This study tests whether a new blood test can accurately detect endometriosis (tissue similar to uterine lining growing outside the uterus). You may qualify if you menstruate regularly, are between 14–49 years old, and either have confirmed endometriosis, had a negative laparoscopy (a scope procedure), or have no endometriosis symptoms.
This study tests a new blood test (HerResolve™) to see if it can accurately detect endometriosis in women who already have pelvic pain or abnormal bleeding and are scheduled for a diagnostic laparoscopy. If accurate, it could offer a less invasive way to diagnose endometriosis in the future.
This Phase 2 study checks whether a new lab test (using samples from your body) can detect signs specific to endometriosis. It may help improve how endometriosis is identified, especially when people are heading toward laparoscopic surgery.
This trial tests a new blood-based test (OCS) that looks for tiny particles from tumor cells to watch for cancer returning after initial treatment. It is for women with ovarian cancer whose CA125 levels were normal before starting treatment.
This study is testing a new blood test that may help detect ovarian cancer earlier. Researchers want to see if it can tell the difference between people with ovarian cancer and those without it.
Hear when a new Endometriosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.